XDNA.TO vs. LONG.TO
XDNA.TO (iShares Genomics Immunology and Healthcare Index ETF) and LONG.TO (CI Global Longevity Economy Fund) are both Health & Biotech Equities funds. XDNA.TO is passively managed, while LONG.TO is actively managed. Over the past 3 years, XDNA.TO returned 16.93%/yr vs 17.35%/yr for LONG.TO. At a 0.34 correlation, their price movements are largely independent.
Performance
XDNA.TO vs. LONG.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XDNA.TO achieves a 33.92% return, which is significantly higher than LONG.TO's 7.64% return.
XDNA.TO
- 1D
- 0.61%
- 1M
- 16.88%
- YTD
- 33.92%
- 6M
- 32.78%
- 1Y
- 71.75%
- 3Y*
- 16.93%
- 5Y*
- —
- 10Y*
- —
LONG.TO
- 1D
- 0.82%
- 1M
- 0.20%
- YTD
- 7.64%
- 6M
- 7.66%
- 1Y
- 21.51%
- 3Y*
- 17.35%
- 5Y*
- 10.40%
- 10Y*
- —
XDNA.TO vs. LONG.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF | 33.92% | 12.10% | 5.54% | -7.84% | -14.85% |
LONG.TO CI Global Longevity Economy Fund | 7.64% | 6.19% | 25.86% | 19.50% | 0.12% |
Correlation
The correlation between XDNA.TO and LONG.TO is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since May 4, 2022 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XDNA.TO vs. LONG.TO — Risk / Return Rank
XDNA.TO
LONG.TO
XDNA.TO vs. LONG.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare Index ETF (XDNA.TO) and CI Global Longevity Economy Fund (LONG.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XDNA.TO | LONG.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.45 | ||
| Sortino ratioReturn per unit of downside risk | +1.82 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.26 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 8.35 | 1.46 | +6.89 |
| Martin ratioReturn relative to average drawdown | 19.59 | 5.21 | +14.38 |
Loading charts...
Drawdowns
XDNA.TO vs. LONG.TO - Drawdown Comparison
The maximum XDNA.TO drawdown since its inception was -45.90%, which is greater than LONG.TO's maximum drawdown of -23.65%. Use the drawdown chart below to compare losses from any high point for XDNA.TO and LONG.TO.
Loading charts...
Drawdown Indicators
| XDNA.TO | LONG.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.90% | -23.65% | -22.25% |
Max Drawdown (1Y)Largest decline over 1 year | -8.64% | -16.39% | +7.75% |
Max Drawdown (3Y)Largest decline over 3 years | -28.29% | -22.45% | -5.84% |
Max Drawdown (5Y)Largest decline over 5 years | — | -23.65% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.91% | +1.91% |
Average DrawdownAverage peak-to-trough decline | -23.18% | -5.66% | -17.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.67% | 4.58% | -0.91% |
Volatility
XDNA.TO vs. LONG.TO - Volatility Comparison
iShares Genomics Immunology and Healthcare Index ETF (XDNA.TO) has a higher volatility of 7.64% compared to CI Global Longevity Economy Fund (LONG.TO) at 6.73%. This indicates that XDNA.TO's price experiences larger fluctuations and is considered to be riskier than LONG.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XDNA.TO | LONG.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.64% | 6.73% | +0.91% |
Volatility (6M)Calculated over the trailing 6-month period | 18.67% | 13.94% | +4.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.18% | 16.87% | +8.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.36% | 17.38% | +7.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.36% | 17.72% | +7.64% |
Dividends
XDNA.TO vs. LONG.TO - Dividend Comparison
XDNA.TO's dividend yield for the trailing twelve months is around 0.24%, while LONG.TO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
LONG.TO CI Global Longevity Economy Fund | 0.00% | 0.00% | 0.00% | 0.33% | 0.00% |
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF | 0.24% | 0.43% | 0.32% | 0.25% | 0.32% |
Frequently Asked Questions
XDNA.TO and LONG.TO have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
They also come from different issuers: iShares and CI.
Find the right allocation for XDNA.TO and LONG.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer